Compare NVAX & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVAX | PRGO |
|---|---|---|
| Founded | 1987 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 1996 | 2013 |
| Metric | NVAX | PRGO |
|---|---|---|
| Price | $9.05 | $10.83 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $11.33 | ★ $19.33 |
| AVG Volume (30 Days) | ★ 4.8M | 2.9M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.28% |
| EPS Growth | ★ 309.76 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,123,479,000.00 | $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 64.69 | N/A |
| 52 Week Low | $6.20 | $9.23 |
| 52 Week High | $11.85 | $28.44 |
| Indicator | NVAX | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 45.45 | 45.27 |
| Support Level | $8.89 | $10.37 |
| Resistance Level | $9.02 | $11.85 |
| Average True Range (ATR) | 0.68 | 0.56 |
| MACD | -0.21 | 0.02 |
| Stochastic Oscillator | 18.10 | 28.69 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.